ALK5 inhibition blocks TGFβ-induced CCN1 expression in human foreskin fibroblasts

Journal of Cell Communication and Signaling

Volumn 8, Issue 1, 2014, Pages 59-63

  Thompson, Katherine ^a   Murphy Marshman, Hannah ^a   Leask, Andrew ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

ALK5; CCN1; CCN2; ctgf; cyr61; Fibroblasts; TGFbeta

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE RICH PROTEIN 61; MESSENGER RNA; NEPHROBLASTOMA OVEREXPRESSED PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SKIN FIBROBLAST;

EID: 84899446834     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-014-0229-7     Document Type: Article

References (34)

1. Abd El Kader T, Kubota S, Janune D, Nishida T, Hattori T, Aoyama E, Perbal B, Kuboki T, Takigawa M (2013) Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family. J Cell Commun Signal 7:11-18
2. Blom IE, Goldschmeding R, Leask A (2001) Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21:473-482
3. Bork P (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327(2):125-130
4. Chen CC, Mo FE, Lau LF (2011) The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276:47329-47337
5. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A (2002) CTGF expression in mesangial cells: involvement of SMADs, MAP kinase and PKC. Kidney Int 62:1149-1159
6. Grotendorst GR, Okochi H, Hayashi N (1996) A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7:469-480 (Pubitemid 26362091)
7. Guo F, Carter DE, Leask A (2011) Mechanical tension increases CCN2/CTGF expression and proliferation in gingival fibroblasts via a TGFβ-dependent mechanism. PLoS One 6(5):e19756
8. Higashiyama H, Yoshimoto D, Kaise T, Matsubara S, Fujiwara M, Kikkawa H, Asano S, Kinoshita M (2007) Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis. Exp Mol Pathol 83:39-46 (Pubitemid 46842964)
9. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276:10594-10601 (Pubitemid 38089227)
10. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ, Goldschmeding R (1998) Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53:853-861 (Pubitemid 28155657)
11. Jun JI, Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 12:676-685
12. Lai CF, Chen YM, Chiang WC, Lin SL, Kuo ML, Tsai TJ (2013) Cysteine-rich protein 61 plays a proinflammatory role in obstructive kidney fibrosis. PLoS One 8:e56481
13. Lawrencia C, Charrier A, Huang G, Brigstock DR (2009) Ethanol-mediated expression of connective tissue growth factor (CCN2) in mouse pancreatic stellate cells. Growth Factors 27:91-99
14. Leask A, Abraham DJ (2004) The control of TGFβ signaling in wound healing and fibrosis. FASEB J 18:816-827
15. Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119:4803-4810 (Pubitemid 46017793)
16. Leask A, Sa S, Holmes A, Shiwen X, Black CM, Abraham DJ (2001) The control of CTGF (ccn2) gene expression in normal and scleroderma fibroblasts. Mol Pathol 54:180-183 (Pubitemid 32539611)
17. Leask A, Holmes A, Black CM, Abraham DJ (2003) Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278:13008-13015 (Pubitemid 36800068)
18. Leask A, Chen S, Pala D, Brigstock DR (2008) Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells. J Cell Commun Signal 2:49-56
19. Leask A, Parapuram SK, Shiwen X, Abraham DJ (2009) Connective tissue growth factor (CTGF, CCN2) gene expression: a potent clinical marker of fibroproliferative disease. J Cell Commun Signal 3:89-94
20. Leivonen SK, Häkkinen L, Liu D, Kähäri VM (2005) Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 124:1162-1169
21. Lemaire R, Farina G, Bayle J, Dimarzio M, Pendergrass SA, Milano A, Perbal B, Whitfield ML, Lafyatis R (2011) Antagonistic effect of the matricellular signaling protein CCN3 on TGF-beta- and Wnt-mediated fibrillinogenesis in systemic sclerosis and Marfan syndrome. J Invest Dermatol 130:1514-1523
22. Liu S, Thompson K, Leask A (2014) CCN2 expression by fibroblasts is not required for cutaneous tissue repair. Wound Repair Regen 22:119-124
23. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K (1999) Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol 181:153-159 (Pubitemid 29400382)
24. Pala D, Kapoor M, Woods A, Kennedy L, Liu S, Chen S, Bursell L, Lyons K, Carter D, Beier F, Leask A (2008) FAK/src suppresses early chondrogenesis: central role of CCN2. J Biol Chem 283:9239-9247
25. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P (1999) Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30:968-976 (Pubitemid 29458286)
26. Perbal B (2013) CCN proteins: a centralized communication network. J Cell Commun Signal 7(3):169-177
27. Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174:1725-1734
28. Riser BL, Bhagavathula N, Perone P, Garchow K, Xu Y, Fisher GJ, Najmabadi F, Attili D, Varani J (2012) Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis. J Cell Commun Signal 6:97-105
29. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ, Leask A (2006) CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 281:10715-10726 (Pubitemid 43855493)
30. Thompson K, Hamilton DW, Leask A (2011) ALK5 inhibition blocks TGFβ-induced CCN2 expression in gingival fibroblasts. J Dent Res 89:1450-1454
31. Tran CM, Smith HE, Symes A, Rittié L, Perbal B, Shapiro IM, Risbud MV (2011) Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc. Arthritis Rheum 63:3022-3031
32. Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A (2006) The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther 8:R36
33. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, Lin A, Yeowell D (2011) Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4:4
34. Xiao YQ, Liu K, Shen JF, Xu GT, Ye W (2009) SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthalmol Vis Sci 50:1698-1706